UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PRINCETON, N.J., March 06, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and spec ...

Details:

• Published: 06/03/2026 21:43 (UTC)
• 📊 Characteristics Score:

  Asset Type: others Sentiment: 0.2 Entropy: 0.1 Relevance: 0.05 Staleness: 0.85 Uncertainty: 0.1 Level-1 Focus: institutional-adoption Level-2 Focus: asset-manager-initiatives

• 🏷️ Tags: #urogen pharma #inducement grants #restricted stock units #rsus #jelmyto #zusdur #biotech #nasdaq

Source: https://rwatimes.io/articles/finviz-uro-gen-pharma-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-1197766647?utm_source=reddit&utm_medium=social&utm_campaign=reddit&utm_content=finviz-uro-gen-pharma-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4-1197766647

Posted from RWA Times Bot